Canaan Partners IX LLC, Director at CytomX Therapeutics, Inc. (CTMX), sold 444,172 shares at $11.18 ($494K) on 2016-11-29, disclosed to the SEC on 2016-12-01.
Open-market sale of $494k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.18 | 22,086 | $247K | 50.0% |
| 2 | $11.18 | 22,086 | $247K | 50.0% |
| 3 | $0.00 | 400,000 | $0 | 0.0% |
| Total | $1.11 avg | 444,172 | $494K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-10 | $303K | — | Filing → |
| CTMX | SELL | 2016-06-10 | $487K | — | Filing → |